Amgen (AMGN) Tops Q2 EPS by 10c; Boosts FY16 Outlook
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $344.72 +2.11%
Revenue Growth %: +2.7%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +2.7%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $2.84, $0.10 better than the analyst estimate of $2.74. Revenue for the quarter came in at $5.69 billion versus the consensus estimate of $5.58 billion.
GUIDANCE:
Amgen sees FY2016 EPS of $11.10-$11.40. Amgen sees FY2016 revenue of $22.5-22.8 billion. The Street sees EPS of $11.18 and revenue of $22.57 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
- Robinhood prices $2B convertible notes offering due 2029
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
